Sars-cov-2 antibodies and immunity: still to explore for covid-19

HIGHLIGHTS

• who: Ribonucleic Acid et al. from the Inc, West Haven, CT, USA have published the research: SARS-CoV-2 Antibodies and Immunity: Still to Explore for COVID-19, in the Journal: (JOURNAL) of July/27,/2022
• what: Anti-coronavirus effectiveness of our Nanoviricide (NV-CoV-2, a broad-spectrum antiviral regimen), in cell culture studies using NL63 and 229-E CoVs.
• future: Prior to filing for human clinical trials the authors plan on conducting studies towards clinical candidate selection to further determine the effectiveness against SARS-CoV-2 perform additional drug development studies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.